FOXO TECHNOLOGIES INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
FOXO TECHNOLOGIES INC. (FOXO) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$149.04 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$141.56K.
- FOXO TECHNOLOGIES INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was -$51.36K.
- FOXO TECHNOLOGIES INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$35.58K.
- FOXO TECHNOLOGIES INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$3.36M.
- FOXO TECHNOLOGIES INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $139.19K, a 361.61% increase from fiscal 2024.
- FOXO TECHNOLOGIES INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $30.15K.
- FOXO TECHNOLOGIES INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$5.48M.
- FOXO TECHNOLOGIES INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$1.34M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 8 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$149.04K 10-Q · filed 2026-08-14 | ||||||||
| 2026-03-31 | -$141.56K 10-Q · filed 2026-05-15 | ||||||||
| 2025-12-31 | $139.19K 10-K · filed 2026-04-15 | ||||||||
| 2025-09-30 | $560.29K 10-Q · filed 2025-11-10 | ||||||||
| 2025-06-30 | $253.52K 10-Q · filed 2026-08-14 | ||||||||
| 2025-03-31 | -$51.36K 10-Q · filed 2026-05-15 | ||||||||
| 2024-12-31 | $30.15K 10-K · filed 2026-04-15 | ||||||||
| 2024-09-30 | -$3.67K 10-Q · filed 2025-11-10 | -$4.00K 10-Q · filed 2024-11-19 | |||||||
| 2024-06-30 | -$5.59K 10-Q · filed 2025-08-19 | -$5.00K 10-Q · filed 2024-08-19 | |||||||
| 2024-03-31 | -$35.58K 10-Q/A · filed 2025-08-19 | -$35.00K 10-Q · filed 2024-06-28 | |||||||
| 2023-12-31 | -$5.48M 10-K · filed 2025-04-15 | -$5.48M 10-K · filed 2024-06-06 | |||||||
| 2023-09-30 | -$5.47M 10-Q · filed 2024-11-19 | ||||||||
| 2023-06-30 | -$5.30M 10-Q · filed 2024-08-19 | ||||||||
| 2023-03-31 | -$3.36M 10-Q · filed 2024-06-28 | ||||||||
| 2022-12-31 | -$1.34M 10-K · filed 2024-06-06 | ||||||||
| 2022-09-30 | $3.60M 10-Q/A · filed 2024-06-04 | ||||||||
| 2021-09-30 | -$408.01K 10-Q · filed 2021-11-15 | ||||||||
| 2021-06-30 | -$253.38K 10-Q · filed 2021-08-16 | ||||||||
| 2021-03-31 | -$114.23K 10-Q · filed 2021-05-17 | ||||||||
| 2020-12-31 | $1.42M 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |